Brand Manager Cardiometabolic Health at Eli Lilly and Company

Brussels, Brussels, Belgium

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Ability to embrace an external focus: understand the cardiometabolic health market landscape, competitive development efforts, and needs of patients, caregivers, physicians, and payers in Belgium
Active participation with medical in defining and implementing Thought Leader action plans and contacts; being connected with customers is essential
Gathering external market and customer insights to tailor the cardiometabolic health community strategy into local Belgian implementation
Collaboration with Patient Advocacy Groups (PAGs) in their educational role
Capacity to engage with internal teams: develop cross-functional relationships with local Marketing, Digital, Medical, and Sales
Engage Sales Reps using the Customer Dialogue Model (get input, enhance materials, transfer with brand ambassadors)
Collaboration with Medical Shared Services, Legal, and Ethics & Compliance, respecting Lilly and local standards
Active collaboration with International/Global teams to implement and translate global strategies into BeLux reality
Ability to prioritize work due to split responsibilities across multiple products and work independently

Responsibilities

Develop, drive, and execute customer/brand plans to ensure product uptake/growth by delivering unparalleled customer experience for the cardiometabolic health portfolio in BeLux
Create and implement a comprehensive cross-functional business/customer plan for successful launches and optimization of existing products, using the EU Therapeutic Area community brand plan as basis
Ensure cardiometabolic health commercialization strategies are embedded into local plans by communicating and influencing stakeholders
Integrate customer insights to translate business objectives into Key Player Objectives and major tactics for desired customer experience
Integrate and optimize channel mix (including digital and patient activation) when defining major tactics
Closely monitor budget related to brands, actions, and strategies
Tactically implement plans focused on adding value to customers (HCP, caregiver, patient) and measure success
Frequently monitor customer plan execution and customer-facing activities

Skills

Brand Management

Marketing Strategy

Customer Insights

Market Access

Thought Leader Engagement

Product Launch

Competitive Analysis

Digital Marketing

Sales Collaboration

Customer Experience

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free